Search research articles
Contact Us
Filters
Showing results (61-70 of 197) with videos related to
Page
of 20
Sort By:
Minerva Medica
|
November 17, 1975
[Controlled double-blind study (SAMe-imipramine) in depressive syndromes]
M Mantero, P Pastorino, A Carolei, et al.
Acta Neurologica
|
May 1, 1976
[Directed therapy of Parkinson's disease. Clinical evaluations and pharmacological choice]
M Casacchia, G Meco, S Fabri, et al.
Journal of Endocrinological Investigation
|
July 1, 1981
Circadian rhythmicity of prolactin secretion in elderly subjects: changes during bromocriptine treatment
A Polleri, P Masturzo, G Murialdo, et al.
Zeitschrift Fur Neurologie
|
April 2, 1973
On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease
C Casati, A Agnoli, A Jori, et al.
Journal of Psychiatric Research
|
January 1, 1976
Effect of s-adenosyl-l-methionine (SAMe) upon depressive symptoms
A Agnoli, V Andreoli, M Casacchia, et al.
Acta Neurologica
|
March 1, 1972
[Intracranial pressure and cerebral circulation in patients with acute cranial injuries]
C Fieschi, A Agnoli, N Battistini, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1986
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation
F Stocchi, S Ruggieri, G Brughitta, et al.
Advances in Neurology
|
January 1, 1982
On the etiopathogenesis of migraine: a possible link between the amines and endorphin hypotheses
A Agnoli, A Denaro, E Ceci, et al.
Neuropsychobiology
|
January 1, 1982
New strategies in the management of Parkinson's disease: a biological approach using a phospholipid precursor (CDP-choline)
A Agnoli, S Ruggieri, A Denaro, et al.
Lancet (London, England)
|
March 11, 1989
Side-effects of subcutaneous apomorphine in Parkinson's disease
S Ruggieri, F Stocchi, A Carta, et al.
Page
of 20
Search research articles
Search
Showing results (61-70 of 197) with videos related to
Sort By:
Page
of 20
Minerva Medica
|
November 17, 1975
[Controlled double-blind study (SAMe-imipramine) in depressive syndromes]
M Mantero, P Pastorino, A Carolei, et al.
Acta Neurologica
|
May 1, 1976
[Directed therapy of Parkinson's disease. Clinical evaluations and pharmacological choice]
M Casacchia, G Meco, S Fabri, et al.
Journal of Endocrinological Investigation
|
July 1, 1981
Circadian rhythmicity of prolactin secretion in elderly subjects: changes during bromocriptine treatment
A Polleri, P Masturzo, G Murialdo, et al.
Zeitschrift Fur Neurologie
|
April 2, 1973
On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease
C Casati, A Agnoli, A Jori, et al.
Journal of Psychiatric Research
|
January 1, 1976
Effect of s-adenosyl-l-methionine (SAMe) upon depressive symptoms
A Agnoli, V Andreoli, M Casacchia, et al.
Acta Neurologica
|
March 1, 1972
[Intracranial pressure and cerebral circulation in patients with acute cranial injuries]
C Fieschi, A Agnoli, N Battistini, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1986
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation
F Stocchi, S Ruggieri, G Brughitta, et al.
Advances in Neurology
|
January 1, 1982
On the etiopathogenesis of migraine: a possible link between the amines and endorphin hypotheses
A Agnoli, A Denaro, E Ceci, et al.
Neuropsychobiology
|
January 1, 1982
New strategies in the management of Parkinson's disease: a biological approach using a phospholipid precursor (CDP-choline)
A Agnoli, S Ruggieri, A Denaro, et al.
Lancet (London, England)
|
March 11, 1989
Side-effects of subcutaneous apomorphine in Parkinson's disease
S Ruggieri, F Stocchi, A Carta, et al.
Page
of 20